Your session is about to expire
← Back to Search
Suture Types for Scarring in Darker Skin Tones
N/A
Recruiting
Led By Melissa Pugliano-Mauro, MD
Research Sponsored by Melissa Pugliano-Mauro
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 years or older
Undergoing dermatologic surgery with planned standard elliptical excision with wound length of 3 cm or greater. Benign and malignant lesions will be included, including those that have undergone Mohs micrographic surgery prior to standard linear closure. All body sites will be included.
Must not have
High-tension closures not amenable to 5-0 simple running epidermal sutures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months from procedure
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether dissolvable or non-dissolvable stitches create better cosmetic results in terms of scarring and pigmentation for patients with darker skin tones.
Who is the study for?
This trial is for adults over 18 with skin color NIS scale of 4 or higher, undergoing dermatologic surgery needing at least a 3 cm incision. They must be able to consent, return for follow-up after 3 months, and can have benign or malignant lesions. It's not for those allergic to suture materials, pregnant women, or cases requiring high-tension closures.
What is being tested?
The study compares dissolvable (fast gut) versus non-dissolvable (polypropylene) sutures in patients of darker skin tones to see which causes less scarring and pigment changes post-surgery. Each patient will receive both types on different halves of the same wound.
What are the potential side effects?
Potential side effects may include varying degrees of dyspigmentation (changes in skin color), scarring where the sutures are placed, and typical risks associated with suture materials such as infection or reaction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am having skin surgery for a lesion larger than 3 cm, including after Mohs surgery.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My wound cannot be closed with simple stitches.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months from procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months from procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
POSAS
Skin hyperpigmentation index
Secondary study objectives
Complications
Scar width
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: B= right/inferior half of woundExperimental Treatment2 Interventions
Patients with skin of color undergoing dermatologic surgery with planned standard elliptical excision with wound length of 3 cm or greater
Group II: A= left/superior half of woundExperimental Treatment2 Interventions
Patients with skin of color undergoing dermatologic surgery with planned standard elliptical excision with wound length of 3 cm or greater
Find a Location
Who is running the clinical trial?
Melissa Pugliano-MauroLead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled
Melissa Pugliano-Mauro, MDPrincipal InvestigatorUniversity of Pittsburgh Medical Center
1 Previous Clinical Trials
30 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My wound cannot be closed with simple stitches.I am 18 years old or older.I can come back for a check-up in 3 months.I am having skin surgery for a lesion larger than 3 cm, including after Mohs surgery.
Research Study Groups:
This trial has the following groups:- Group 1: B= right/inferior half of wound
- Group 2: A= left/superior half of wound
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger